Paperonium

Cancer care · Lancet Reg Health Am · 2026

The paper’s summary: a clear COVID drop in prompt bowel-cancer treatment. Its own table: maybe none.

The summary: all treatmentsa clear dropThe paper’s table:all treatmentscould be no dropChemotherapy andsurgery, eachcalled clear; maybe none−0.091 to −0.022−0.091 to 0.022−0.0960.018−0.1−0.0500.05no sudden changefellrose
The summary:all treatmentsa clear dropThe paper’s table:all treatmentscould be no dropChemotherapyand surgery, eachcalled clear;maybe none−0.022−0.091−0.0910.022−0.0960.018−0.1−0.0500.05no sudden changefellrose

Sudden April 2020 change in prompt bowel-cancer treatment (started within 30 days)

The paper says

The paper’s summary: as COVID hit in April 2020, the monthly rate of prompt bowel-cancer treatment (any kind, within 30 days) fell suddenly by 0.035 (its unit is unclear), with a range of −0.091 to −0.022: wholly below zero. It calls the drop “significant”.

Its own data show

The paper’s table and results text print −0.091 to +0.022. Only that centres on −0.035: halfway between −0.091 and +0.022 is −0.0345, but between −0.091 and −0.022 it is −0.0565. This range crosses zero, yet the text still calls the drop significant, as the summary does for chemotherapy and surgery, both printed −0.096 to +0.018.

A range spans the plausible true values, centred on the best guess. Only a range wholly below zero makes a drop “significant”: unlikely to be chance. This April figure was the paper’s only measure of a sudden drop in prompt treatment overall. A separate whole-year figure, 88% of the level expected without COVID, shows a shortfall, not when it struck.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

The early impact of the COVID-19 pandemic on access to colorectal cancer treatment in Brazil: a spatial and interrupted time-series analysis · Lancet Reg Health Am (2026) · doi:10.1016/j.lana.2026.101406